Texas cancer research grants total $69.7 million for diverse projects

The Cancer Prevention and Research Institute of Texas (CPRIT) Oversight Committee convened on May 21, 2025, to discuss a significant slate of funding awards aimed at advancing cancer research across the state. The committee reviewed a total of 47 grant applications, requesting nearly $70 million, which includes new initiatives designed to enhance research capabilities at Texas institutions.

A key highlight from the meeting was the introduction of three new Research Funding Announcements (RFAs), developed with input from the Geographic Diversity Advisory Committee. These RFAs are intended to support investigator-initiated research and core facilities at institutions eligible for CPRIT funding. The committee emphasized the importance of these grants in addressing eight program priorities, including recruitment and innovative research projects.

Among the 19 core facility grants submitted, 11 were recommended for funding. Notably, four of these grants focus on drug discovery, a critical area for CPRIT's mission. One unique grant supports research on extracellular vesicles, marking a first for Texas and promising new avenues for understanding cancer development and treatment responses.

The committee also reviewed high-impact, high-risk research awards, with 96 applications received and 17 recommended for funding. These grants span various aspects of cancer research, including the development of new therapies and diagnostic techniques, as well as cancer prevention strategies.

Additionally, the meeting addressed early clinical investigator awards, which provide essential support for emerging researchers in patient-oriented studies. The committee recommended three grants in this category, highlighting the importance of nurturing new talent in clinical research.

As CPRIT continues to allocate funds to innovative projects, the outcomes of these grants are expected to significantly impact cancer research and treatment in Texas, ultimately benefiting the community by fostering advancements in prevention and care. The committee's commitment to supporting diverse research initiatives reflects a broader goal of enhancing the state's capacity to combat cancer effectively.